Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Wakefield Website

Lalage M. Wakefield, D.Phil.

Selected Publications

1)  Luger D, Yang Y, Raviv A, Weinberg D, Banerjee S, Lee M, Trepel J, Yang L, Wakefield L.
Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.
PLOS One. 2013.
In Press. [Journal]
2)  Hu Y, Ling B, Geiger T, Goldberer N, Walker R, Green J, Wakefield L, Hunter K.
Genetic Background May Contribute to PAM50 Gene Expression Breast Cancer Subtype Assignments.
PLOS One. 8: e72287, 2013.
3)  Wakefield LM, Hill CS.
Beyond TGFß: roles of other TGFß superfamily members in cancer.
Nat. Rev. Cancer. 13: 328-41, 2013.
4)  Stuelten CH, Cervoni-Curet FN, Busch JI, Sutton E, Webster JD, Kavalukas SL, Wakefield LM, Barbul A, Niederhuber JE.
SDF-1a Mediates Wound-Promoted Tumor Growth in a Syngeneic Orthotopic Mouse Model of Breast Cancer.
PLoS ONE. 8: e60919, 2013.
5)  Luger D, Wakefield L.
Ben-Baruch A, eds.
Inflammation and beyond: complex roles for TGF-beta in the tumor microenvironment. In: The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis.
Bentham Science Publishers; 2012. p. 121-152 In Press. [Book Chapter]
6)  Kohn EA, Yang Y, Du Z, Nagano Y, Van Schyndle CM, Herrmann MA, Heldman M, Chen J, Stuelten CH, Flanders KC, Wakefield LM.
Biological responses to TGF-beta in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression.
Mol. Cancer Res. 10: 1389-99, 2012.
7)  Matsubara T, Tanaka N, Sato M, Kang DW, Krausz KW, Flanders KC, Ikeda K, Luecke H, Wakefield LM, Gonzalez FJ.
TGF-ß-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.
J. Lipid Res. 53: 2698-707, 2012.
8)  Kohn EA, Du Z, Sato M, Van Schyndle CM, Welsh MA, Yang Y, Stuelten CH, Tang B, Ju W, Bottinger EP, Wakefield LM.
A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFbeta signaling in the mammary gland.
Breast Cancer Res. 12: R83, 2010.
9)  Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP.
Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
PLoS ONE. 5: e9201, 2010.
10)  Figueroa JD, Flanders KC, Garcia-Closas M, Anderson WF, Yang XR, Matsuno RK, Duggan MA, Pfeiffer RM, Ooshima A, Cornelison R, Gierach GL, Brinton LA, Lissowska J, Peplonska B, Wakefield LM, Sherman ME.
Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Breast Cancer Res. Treat. 121: 727-35, 2010.
Click Here to View Expanded Bibliography.

This page was last updated on 9/4/2013.